Clinical Trials Insight: 700013891
Latest Information Update: 20 Jul 2006
Price :
$35 *
At a glance
- Drugs Bederocin (Primary)
- Indications Impetigo; Methicillin-resistant Staphylococcus aureus infections; Vancomycin-resistant Staphylococcus aureus infections
- Focus Adverse reactions
- Sponsors Cardiovascular Systems
- 20 Jul 2006 New trial record.